These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 10100712)
1. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma. Hiyama E; Hiyama K; Yokoyama T; Fukuba I; Yamaoka H; Shay JW; Matsuura Y Clin Cancer Res; 1999 Mar; 5(3):601-9. PubMed ID: 10100712 [TBL] [Abstract][Full Text] [Related]
2. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction. Crabbe DC; Peters J; Seeger RC Diagn Mol Pathol; 1992 Dec; 1(4):229-34. PubMed ID: 1342970 [TBL] [Abstract][Full Text] [Related]
3. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595 [TBL] [Abstract][Full Text] [Related]
4. MYCN protein expression as a predictor of neuroblastoma prognosis. Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553 [TBL] [Abstract][Full Text] [Related]
5. Detection of n-myc gene amplification in neuroblastoma by comparative, in situ,and real-time polymerase chain reaction. Melegh Z; Bálint I; Tóth E; Csernák E; Szentirmay Z; Nagy K Pediatr Pathol Mol Med; 2003; 22(3):213-22. PubMed ID: 12746172 [TBL] [Abstract][Full Text] [Related]
6. [Detection of MYCN mRNA in neuroblastoma cell lines by quantitative RT-PCR]. Feng C; Tang SQ; Wang JW; Liu LZ; Gao XN; Long H Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):47-50. PubMed ID: 17306077 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of MYCN amplification in a child with stroma-rich neuroblastoma (ganglioneuroblastoma). Lorenzana AN; Zielenska M; Thorner P; Gerrie B; Weitzman S; Squire J Pediatr Pathol Lab Med; 1997; 17(6):875-83. PubMed ID: 9353827 [TBL] [Abstract][Full Text] [Related]
8. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification. Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322 [TBL] [Abstract][Full Text] [Related]
9. Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma. Gallego S; Reventos J; Sanchez de Toledo J; Munell F Anticancer Res; 1998; 18(2A):1211-5. PubMed ID: 9615790 [TBL] [Abstract][Full Text] [Related]
10. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897 [TBL] [Abstract][Full Text] [Related]
11. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1. Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909 [TBL] [Abstract][Full Text] [Related]
12. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR. Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700 [TBL] [Abstract][Full Text] [Related]
14. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177 [TBL] [Abstract][Full Text] [Related]
15. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods]. Melegh Z; Bálint I; Nagy K; Magyarosy E; Galántai I; Szentirmay Z Magy Onkol; 2002; 46(1):43-8. PubMed ID: 12050681 [TBL] [Abstract][Full Text] [Related]
16. MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification. Spitz R; Hero B; Skowron M; Ernestus K; Berthold F Eur J Cancer; 2004 Dec; 40(18):2753-9. PubMed ID: 15571958 [TBL] [Abstract][Full Text] [Related]
17. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Krams M; Claviez A; Heidorn K; Krupp G; Parwaresch R; Harms D; Rudolph P Am J Pathol; 2001 Nov; 159(5):1925-32. PubMed ID: 11696453 [TBL] [Abstract][Full Text] [Related]
18. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes. Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues. Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675 [TBL] [Abstract][Full Text] [Related]
20. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]